ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,261Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 780

$712K Total Retail Price of All Prescriptions

Rank: 158 out of 780

583 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 583 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 583 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 11,199 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 690 519 1 2
LEVOTHYROXINE SODIUM 548 412 2 5
CARVEDILOL 541 437 3 14
OMEPRAZOLE 540 397 4 3
LISINOPRIL 508 390 5 6
BISOPROLOL-HYDROCHLOROTHIAZIDE 502 331 6 95
CITALOPRAM HBR 459 321 7 23
RANITIDINE HCL 353 271 8 39
PRAVASTATIN SODIUM 344 263 9 9
METOPROLOL SUCCINATE 336 230 10 20
MELOXICAM 328 246 11 16
ZOLPIDEM TARTRATE 310 170 12 17
LOSARTAN POTASSIUM 299 229 13 18
METFORMIN HCL 291 202 14 8
AMLODIPINE BESYLATE 275 222 15 4
LOSARTAN-HYDROCHLOROTHIAZIDE 249 169 16 33
TRAMADOL HCL 233 120 17 15
FELODIPINE ER 228 199 18 126
LISINOPRIL-HYDROCHLOROTHIAZIDE 226 159 19 26
ATORVASTATIN CALCIUM 222 136 20 12
CIPROFLOXACIN HCL 209 142 21 49
TAMSULOSIN HCL 209 184 21 36
ESTRADIOL 203 76 R 23 122
PREDNISONE 201 141 24 40
GABAPENTIN 190 113 25 13
IBUPROFEN 176 131 26 93
ALLOPURINOL 169 116 27 29
FUROSEMIDE 167 127 28 7
CEFDINIR 166 116 29 180
NEXIUM 163 108 30 22
GLIPIZIDE ER 161 135 31 109
HYDRALAZINE HCL 160 140 32 54
PANTOPRAZOLE SODIUM 157 137 33 25
DONEPEZIL HCL 149 131 34 31
CRESTOR 143 120 35 32
NABUMETONE 142 94 36 171
ATENOLOL 141 58 37 21
AZITHROMYCIN 133 93 38 38
POTASSIUM CHLORIDE 126 99 39 11
METFORMIN HCL ER 120 93 40 43
ISOSORBIDE MONONITRATE ER 109 99 41 60
LOVASTATIN 108 71 42 47
HYDROCHLOROTHIAZIDE 99 91 43 10
ESCITALOPRAM OXALATE 95 30 44 61
SPIRONOLACTONE 94 61 45 53
INDAPAMIDE 88 70 46 190
KLOR-CON M20 84 45 47 57
NIFEDIPINE ER 82 73 48 115
CYCLOBENZAPRINE HCL 82 42 R 48 42
GLYBURIDE-METFORMIN HCL 81 35 R 50 108
LANTUS SOLOSTAR 79 37 51 121
SERTRALINE HCL 76 35 52 27
FLUCONAZOLE 75 39 53 111
HYDROCODONE-ACETAMINOPHEN 72 43 S3 54 1
FINASTERIDE 69 65 55 150
METOPROLOL TARTRATE 67 51 56 19
ADVAIR DISKUS 67 32 56 68
CLOPIDOGREL 67 56 56 34
WARFARIN SODIUM 63 43 59 24
BUMETANIDE 62 34 60 96
PRAMIPEXOLE DIHYDROCHLORIDE 62 41 60 156
TRAZODONE HCL 62 30 60 35
LEVEMIR FLEXPEN 60 24 63 211
CYMBALTA 59 34 64 51
TRIAMTERENE-HCTZ 57 38 65 37
CEPHALEXIN 57 32 65 105
LACTULOSE 55 44 67 178
CLONIDINE HCL 54 28 68 28
AMLODIPINE BESYLATE-BENAZEPRIL 53 50 69 50
GEMFIBROZIL 53 19 69 104
PLAVIX 53 40 69 45
LEVOFLOXACIN 53 40 69 76
CLOTRIMAZOLE-BETAMETHASONE 52 43 73 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.